RxDoctor Payments Data

Margaret Arnold, MD

Vascular Surgery · Baltimore, MDNPI 1043439268

Payments from drug & device makers

What this record shows

Intuitive Surgical accounts for 62.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $1,643 and has fallen 96.2% since, to $63 in 2025. That places this record below the midpoint for vascular surgery clinicians in MD, where the typical reported total is $3,095.

$2,417in general payments, 2019–2025

Across 25 payments — averaging $96.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Inari Medical, Inc.$368
  • Bolton Medical Inc$128
  • Johnson & Johnson$125
  • Boston Scientific$86
  • W. L. Gore & Associates, Inc.$73
  • plus $122 from 4 others
$17,116in research payments, 2019–2025

Across 11 payments — averaging $1555.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$17K

What the payments were for

  • Travel & lodging$1,41959%
  • Food & beverage$99841%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,417 in reported general payments places this provider in the 45th percentile of 104 vascular surgery providers in Maryland.

See all vascular surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$66,680
Medicare patients
217
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$6,848

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →